Prophylactic mastectomy: The Rotterdam experience

Breast

Volumn 12, Issue 6, 2003, Pages 357-361

  van Geel, A N ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Breast reconstruction; Hereditary breast cancer; Prophylactic mastectomy

Indexed keywords

BRCA2 PROTEIN;

ANXIETY; ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER GROWTH; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; JOINT CONTRACTURE; MAJOR CLINICAL STUDY; MASTECTOMY; NETHERLANDS; ONSET AGE; PECTORAL MUSCLE; POPULATION RESEARCH; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROGNOSIS; SEXUAL BEHAVIOR; SILICONE PROSTHESIS; SURVIVAL RATE;

EID: 0347519225     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(03)00136-X     Document Type: Article

References (21)

1. Brekelmans C T M, Seynaeve C, Bartels C C M, Tilanus-Linthorst M M A, Meijers-Heijboer E J, Crepin C M G, van Geel A N, Menke M, Verhoog L C, van den Ouweland A, Obdeijn I M, Klijn J G M. Effectiveness of breast cancer surveillance in BRCA 1/2 gene mutation carriers and women with a high familial risk. J Clin Oncol 2001; 19: 924-930.
2. Meijers-Heijboer E J, Verhoog L C, Brekelmans C T M et al. Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation. Lancet 2000; 355: 2015-2020.
3. Metcalfe K A, Goel V, Lickley L, Semple J, Narod S A. Prophylactic bilateral mastectomy: patterns of practice. Cancer 2002; 95: 236-242.
4. Contant C M E, Menke-Pluijmers M B E, Seynaeve C, Meijers-Heijboer E J, Klijn J G M, Verhoog L C et al. Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation. Management, morbidity and oncological aspects in 112 consecutive patients. Eur J Surg Oncol 2002; 28: 627-632.
5. van Geel A N, Contant C M E, Tjong Joe Wai R, Schmitz P I M, Eggermont A M M, Menke-Pluijmers M M E. Mastectomy by inverted drip incision and immediate reconstruction (MIDIIR): Data from 510 cases. Ann Surg Oncol 2003; 10: 389-395.
6. Contant C M E, van Geel A N, van der Holt B, Griep C, Tjong Joe Wai R, Wiggers Th. Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: the adverse effect of radiotherapy. Eur J Surg Oncol 2000; 26: 344-350.
7. Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan et al. Outcome of preventive surgery and screening for breast cancer and ovarian cancer in BRCA mutation carriers. J Clin Oncol 2002; 20: 1164-1166.
8. Hartmann L C, Schaid D J, Woods J E, Crotty T P, Myers J L, Arnold P G et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 1999; 340: 77-84.
9. Hartman L C, Selllers T A, Schaid D J, Frank T S, Soderberg C L, Sitta D L et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Nat Cancer Inst 2001; 93: 1633-1637.
10. Meijers-Heijboer E J, van Geel A N, van Putten L J et al. Efficacy of prophylactic bilateral mastectomy in women with a BRCA1/ BRCA2 mutation: first prospective study. N Engl J Med 2001; 345: 159-164.
11. Schrag D, Kuntz K M, Garbor J E, Weeks J C. Decision analysis- effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997; 336: 1465-1471.
12. Verhoog L C, Brekelmans C T, Seynaeve C, Meijers-Heijboer E J, Klijn J G. Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer. Br J Cancer 2000; 83: 384-386.
13. McDonell S K, Schaid D J, Myers J L, Grant C S, Donohue J H, Woods J E et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and familial history of breast cancer. J Clin Oncol 2001; 19: 3938-3943.
14. Peralta E A, Ellenhorn J D, Wagman L D, Dagis A, Andersen J S, Chu D Z. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 2000; 180: 439-445.
15. Brekelmans C T, Voogd A C, Botke G, van Geel B N, Rodrigus P, Rutgers E J et al. Family history of breast cancer and local recurrence after breast conserving therapy; The Dutch Study Group on local recurrence after breast conserving (BORST). Eur J Cancer 1999; 35: 620-626.
16. Verhoog L C, Brekelmans C T, Seynaeve C, van den Bosch L M, Dahmen G, van Geel A N et al. Survival in hereditary breast cancer associated with germline mutations of BRCA2. J Clin Oncol 1999; 17: 3396-3402.
17. Payne D K, Biggs C, Tran K N, Borgen PI, Massie M J. Women's regret after bilateral prophylactic mastectomy. Ann Surg Oncol 2000; 7: 150-154.
18. Lodder L N, Frets P G, Trijsburg R W, Meijers-Heijboer E J, Klijn J G M, van Geel A N. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 2002; 73: 97-102.
19. Brassiere P. Personal communication.
20. Frost M H, Schaid D J, Sellers T A, Slezak J M, Arnold P G, Woods J L et al. Long-term satisfaction and psychosocial and social function following bilateral prophylactic mastectomy. JAMA 2000; 284: 319-324.
21. van Oostrom I, Meijers-Heiiboer E J, Lodder L N, Duivenvoorde H J, van Gool A R, Seynaeve C, van der Meer C A, Klijn J G M, van Geel A N, Wladimiroff J W, Tibben A. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5 year follow-up study, in press.